Disopyramide phosphate: pharmacokinetic and pharmacologic relationships of a new antiarrhythmic agent.
D000284:Administration, Oral; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology* / Q000652:urine; D003201:Computers; D001728:Dicumarol / Q000097:blood / Q000378:metabolism; D004285:Dogs; D004562:Electrocardiography; D004790:Enzyme Induction; D005260:Female; D006207:Half-Life; D006801:Humans; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D007700:Kinetics; D008297:Male; D008780:Methyltransferases / Q000378:metabolism; D008954:Models, Biological; D009119:Muscle Contraction / Q000187:drug effects; D010634:Phenobarbital / Q000494:pharmacology; D010710:Phosphates / Q000378:metabolism / Q000494:pharmacology; D011725:Pyridines / Q000378:metabolism* / Q000494:pharmacology*; D051381:Rats
D000889:Anti-Arrhythmia Agents; D010710:Phosphates; D011725:Pyridines; D001728:Dicumarol; D008780:Methyltransferases; D010634:Phenobarbital